✦ LIBER ✦

Dephosphorylation on Tyrosine of Epidermal Growth Factor Receptor Is Inhibited by Ca2+ Pretreatment in Isolated Liver Membrane

✍ Scribed by S. Katoh; A. Funayama; H. Kohno; Y. Ohkubo

Book ID: 115564732
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 423 KB
Volume: 307
Category: Article
ISSN: 0003-9861
DOI: 10.1006/abbi.1993.1559

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The dephosphorylation characteristics of

The dephosphorylation characteristics of the receptors for epidermal growth factor and platelet-derived growth factor in Swiss 3T3 cell membranes suggest differential regulation of receptor signalling by endogenous protein-tyrosine phosphatases

✍ Frank-D. Böhmer; Sylvia-Annette Böhmer; Carl-Henrik Heldin 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 504 KB

Inhibition of Ca2+/calmodulin-dependent

Inhibition of Ca2+/calmodulin-dependent protein kinase or epidermal growth factor receptor tyrosine kinase abolishes lysophosphatidic acid-mediated DNA-synthesis in human myometrial smooth muscle cells

✍ Ulrika K. Nilsson; Samuel P.S. Svensson 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Human myometrial smooth muscle cells (SMCs) were used to evaluate the proliferative activity of lysophosphatidic acid (LPA). This study specifically focuses on the role of Ca(2+)/calmodulin-dependent protein (CaM) kinase and epidermal growth factor (EGF) receptor tyrosine kinase. Myometrial SMCs wer

Irreversible inhibition of epidermal gro

Irreversible inhibition of epidermal growth factor receptor tyrosine kinase with In Vivo activity by N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]-2-butynamide (CL-387,785)

✍ Carolyn M. Discafani; Marion L. Carroll; M.Brawner Floyd Jr.; Irwin J. Hollander 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 358 KB

Inhibition of proliferation and inductio

Inhibition of proliferation and induction of apoptosis in breast cancer cells by the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor ZD1839 (‘Iressa’) is independent of EGFR expression level

✍ Manuela Campiglio; Alberta Locatelli; Clelia Olgiati; Nicola Normanno; Giulia So 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB 👁 2 views

High expression of the epidermal growth factor receptor (EGFR) in breast carcinoma confers a growth advantage to the tumor cells. The EGFR tyrosine kinase inhibitor (EGFR-TKI) ZD1839 ('Iressa') has clinical activity in a wide range of tumor types, although the mechanism(s) by which it exerts its ant

Retractions: 4,5-Dianilinophthalimide: A

Retractions: 4,5-Dianilinophthalimide: A Protein-Tyrosine Kinase Inhibitor with Selectivity for the Epidermal Growth Factor Receptor Signal Transduction Pathway and Potent in vivo Antitumor Activity; Selective Inhibition of the Platelet-Derived Growth Factor Signal Transduction Pathway by a Protein-Tyrosine Kinase Inhibitor of the 2-Phenylaminopyrimidine Class

📂 Article 📅 1998 🏛 National Academy of Sciences 🌐 English ⚖ 238 KB

p42IP4/Centaurin α1, a Brain-specific Pt

p42IP4/Centaurin α1, a Brain-specific PtdIns(3,4,5)P3/Ins(1,3,4,5)P4-binding Protein: Membrane Trafficking Induced by Epidermal Growth Factor is Inhibited by Stimulation of Phospholipase C-coupled Thrombin Receptor

✍ Fariba Sedehizade; Christoph von Klot; Theodor Hanck; Georg Reiser 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 508 KB